Stock option plan

3 Months Ended

Jan. 31, 2020

Share-based Payment Arrangement [Abstract]

Stock option plan

Note 13 – Stock option plan:

On September 4, 2014, the Board approved the grant of an aggregate of 246,000 non-qualified share options under FREIT’s Equity Incentive Plan (“the Plan”) to certain FREIT executive officers, the members of the Board and certain employees of Hekemian & Co., Inc., FREIT’s managing agent. The options have an exercise price of $18.45 per share, fully vested on September 3, 2019 and will expire 10 years from the date of grant, which will be September 3, 2024.

On November 10, 2016, the Board approved the grant of an aggregate of 38,000 non-qualified share options under the Plan to two members of the Board who were appointed to the Board during Fiscal 2016. The options have an exercise price of $21.00 per share, will vest in equal annual installments over a 5-year period and will expire 10 years from the date of grant, which will be November 9, 2026.

On May 3, 2018, the Board approved the grant of an aggregate of 38,000 non-qualified share options under the Plan to two members of the Board who were appointed to the Board during Fiscal 2018. The options have an exercise price of $15.50 per share, will vest in equal annual installments over a 5-year period and will expire 10 years from the date of grant, which will be May 2, 2028.

On March 4, 2019, the Board approved the grant of an aggregate of 5,000 non-qualified share options under the Plan to the Chairman of the Board. The options have an exercise price of $15.00 per share, will vest in equal annual installments over a 5-year period and will expire 10 years from the date of grant, which will be March 3, 2029.

As of January 31, 2020, 442,060 shares are available for issuance under the Plan.

The following table summarizes stock option activity for the three-month period ended January 31, 2020:

	No. of Options		Weighted Average
	Outstanding		Exercise Price
Options outstanding beginning of period		310,740	$	18.35
Options granted during period		—		—
Options forfeited/cancelled during period		—		—
Options outstanding end of period		310,740	$	18.35
Options vested and expected to vest		308,310
Options exercisable at end of period		260,140

For the three-month periods ended January 31, 2020 and 2019, compensation expense related to stock options granted amounted to approximately $12,000 and $34,000, respectively. At January 31, 2020, there was approximately $106,000 of unrecognized compensation cost relating to outstanding non-vested stock options to be recognized over the remaining weighted average vesting period of approximately 2.9 years.

The aggregate intrinsic value of options vested and expected to vest and options exercisable at January 31, 2020 was approximately $1,897,000 and $1,538,000, respectively.